+1 (424) 212-4087

Azoospermia in Torrance: A Complete Guide to a Zero Sperm Count, Genetic Testing, and Sperm Retrieval

A semen analysis report that says “no sperm seen” is one of the most frightening results a couple can receive on a fertility journey. Many men assume it means there is no chance of a biological child. In reality, a zero sperm count on a semen analysis — called azoospermia — is a diagnosis with structure, subtypes, specific causes, and, in many cases, effective pathways to retrieving usable sperm for IVF. The most important thing to understand early is that “no sperm seen in the ejaculate” does not automatically mean “no sperm being produced,” and it certainly does not mean “no options.”

This guide is the male-factor companion to our cluster of Torrance fertility articles. It explains what azoospermia actually means (and what it does not), how the diagnosis is confirmed, the two main categories with very different causes and outlooks, the hormonal and genetic testing that comes before treatment, sperm retrieval procedures, how retrieved sperm is used with IVF and ICSI, and what happens if retrieval does not find sperm. It links to our related guides so you can pair this information with the rest of the diagnostic and treatment picture.

What Azoospermia Actually Means — and What It Does Not

Azoospermia means that a semen analysis finds no sperm in the ejaculate. It is distinct from related findings that are often confused with it:

  • Oligozoospermia. Sperm are present but the concentration is below the reference range — a low count, not a zero count.
  • Cryptozoospermia. Sperm are so rare that they are missed on a routine initial look but can be found on a more thorough search of the sample (often after spinning it down). Some men are reclassified from azoospermia to cryptozoospermia on repeat testing, and that distinction matters clinically.
  • Aspermia. No semen is ejaculated at all — a volume problem, which is different from a sperm-production problem (for example, retrograde ejaculation, where semen travels backward into the bladder).
  • Necrozoospermia / non-viable sperm. Sperm are present but not moving or viable — again, a different situation from true azoospermia.

The key distinction doctors will work to establish is whether sperm are being produced inside the testicles but blocked from reaching the semen (a plumbing problem), or are not being produced adequately in the first place (a production problem). These are the two main categories of azoospermia — obstructive and non-obstructive — and they have different causes, different tests, and different treatment paths. MedlinePlus describes semen analysis and its reference values clearly, and the interpretation of a zero-count result always starts with confirming the finding properly (MedlinePlus: Semen analysis).

A single “no sperm seen” report is the beginning of an evaluation, not the end of the road. Every credible published guideline emphasizes confirming the finding before anyone discusses prognosis — rare sperm are missed more often than patients expect.

How Common Is Azoospermia?

Published urology and reproductive medicine guidelines estimate that azoospermia affects roughly 1 in 100 men in the general population, and that it is found in roughly 10–15% of men being evaluated for infertility. These are population-level figures from published research, not predictions about any individual. For context on the bigger picture: male factors contribute substantially to infertility overall — authoritative sources such as MedlinePlus note that a male factor plays a role in about half of infertile couples (MedlinePlus: Infertility), which is why our infertility workup guide recommends evaluating both partners from the start rather than sequencing testing woman-first.

The single most useful message for couples who have just received this diagnosis: azoospermia is one of the better-defined and better-solved problems in fertility medicine. The categories are clear, the diagnostic steps are standardized, and sperm-retrieval techniques plus IVF with ICSI were, historically, developed in large part to solve exactly this problem.

Step One: Confirming a True Zero Count

Before any classification, testing, or treatment talk, the finding itself has to be verified. Professional guidelines recommend specific steps because a single sample can mislead:

  • Repeat the analysis. Sperm production varies from sample to sample, and laboratory handling differences matter. Azoospermia should be confirmed on at least one repeat analysis after the first zero result.
  • The "spin test." The repeat sample is centrifuged and the pellet examined microscopically for rare sperm. Published guidelines recommend this step because it distinguishes true azoospermia from cryptozoospermia — and finding even a few sperm in the spun pellet can change the whole plan, since rare ejaculated sperm can sometimes be used for ICSI without any retrieval procedure at all.
  • Review collection details. Abstinence window, illness in the preceding months, fever, incomplete collection, and sample timing all affect results, as we describe in the semen-analysis section of our pre-IVF testing guide. A sample collected during or right after a febrile illness can temporarily drop counts dramatically.

If repeat testing — including the centrifugation step — still finds no sperm, the evaluation moves to classification: obstructive versus non-obstructive.

The Two Types: Obstructive vs. Non-Obstructive Azoospermia

Everything that follows depends on which category applies. The physical exam and hormone panel usually point clearly to one or the other; occasionally, both exist together (production that is only partly impaired plus partial obstruction).

Feature Obstructive azoospermia (OA) Non-obstructive azoospermia (NOA)
Sperm production Normal — sperm are made but blocked from reaching the semen Reduced or absent — the testicles make few or no mature sperm
Testicle size Usually normal Often smaller than average
FSH (a brain hormone that signals the testicle) Usually normal Often elevated (the brain is "pushing harder" on a testicle that is underperforming)
Typical causes Missing vas deferens (CFTR-related), vasectomy, infection, prior surgery, injury Genetic conditions, developmental factors, hormone disorders, chemotherapy or radiation, unexplained causes
Sperm retrieval outlook Sperm recovered in nearly all published series Sperm recovered for roughly 40–60% of men across published series, varying with cause and technique

The retrieval figures above are typical published ranges from review studies and professional society analyses — they describe groups, not guarantees, and individual outcomes depend on the specific cause, the technique used, and findings at the time of the procedure. No clinic can promise a retrieval result in advance.

Obstructive Azoospermia: Causes

In obstructive azoospermia, the testicles are producing sperm, but the outflow path is blocked somewhere between the testicle and the urethra. Common causes include:

  • Congenital absence of the vas deferens (CBAVD). Some men are born without the tubes that carry sperm from the testicle. This is closely tied to the gene for cystic fibrosis (CFTR): most men with CBAVD carry at least one CFTR variant, and MedlinePlus Genetics describes the CFTR–reproductive connection in detail (MedlinePlus Genetics: Cystic fibrosis). This is why genetic testing of the man and screening of the female partner are standard before treatment in this situation — covered in the genetic-testing section below.
  • Vasectomy. A vasectomy is a deliberate obstruction. Whether the better path is surgical reversal or sperm retrieval with IVF depends on time since the vasectomy, the female partner’s age, and cost trade-offs — discussed in its own section below.
  • Infection. Infections such as epididymitis can scar the fine ducts of the epididymis. Scarring is usually permanent, but the production side keeps working, which is why retrieval outlook in OA is favorable.
  • Prior surgery or injury. Groin, scrotal, pelvic, or prostate surgery can interrupt the duct system, as can trauma. Hernia repair with mesh is a recognized cause in some cases.
  • Ejaculatory duct obstruction. Blockage where the ducts enter the urethra; low ejaculate volume with a very acidic pH is a supporting clue on the labs.

Non-Obstructive Azoospermia: Causes

In non-obstructive azoospermia, the problem is sperm production itself. Causes fall into several groups:

  • Genetic conditions. Klinefelter syndrome (an extra X chromosome, occurring in roughly 1 in 500–1,000 male births according to MedlinePlus Genetics, and a common cause of NOA — MedlinePlus Genetics: Klinefelter syndrome) and deletions of the Y chromosome’s AZF sperm-production regions (described by MedlinePlus Genetics: Y chromosome infertility) are the two most important. Many other cases have a genetic basis that current testing does not fully explain.
  • Hormone disorders. When the brain does not send enough signal (FSH and LH) to the testicles — hypogonadotropic hypogonadism — production stalls. This is one of the few directly treatable causes of azoospermia, discussed in the section on hormonal therapy below.
  • Childhood and developmental factors. Undescended testicles (cryptorchidism), especially when bilateral and corrected late, are associated with reduced sperm production in adulthood.
  • Chemotherapy or radiation. Many cancer treatments permanently damage sperm production, though the degree depends on the agents and doses. This is exactly why fertility preservation — banking sperm before treatment — is emphasized for anyone facing gonadotoxic therapy; our fertility preservation guide covers the preservation pathway for couples.
  • Varicocele. Enlarged veins around the testicle more commonly lower counts than eliminate them, but severe cases appear in azoospermia evaluations; surgical repair is considered case-by-case and its benefit for restoring sperm to the ejaculate is not guaranteed.
  • Medications and substances. Long-term anabolic steroid use, testosterone therapy, opioids, and certain other medications suppress sperm production — often significantly, and often reversibly.
  • Idiopathic. In many men, no cause is identified even after a complete evaluation. “Unexplained” does not mean “untreatable,” but it does mean counseling is based more on testing results and retrieval findings than on a named diagnosis.

The Hormone Panel: What Each Pattern Suggests

A blood panel (typically drawn at least twice when results are borderline, because hormone levels fluctuate) helps sort OA from NOA and identifies treatable causes. The two most informative values are FSH and testosterone:

Pattern Most consistent with What happens next
Normal FSH, normal testosterone, normal-size testicles Obstructive azoospermia Confirm with physical exam, imaging/assessment of the ducts; plan retrieval; evaluate CFTR when indicated
High FSH (with small testicles) Non-obstructive azoospermia — testicular production failure Genetic testing (karyotype, Y-microdeletion) before any retrieval planning
Low FSH and low testosterone Hypogonadotropic hypogonadism — the brain is not signaling Treatable: hormonal therapy to restart signaling, with repeat semen analyses over months
Normal FSH with clearly low testosterone Mixed or partial picture; possible exogenous suppression Review medications (testosterone, anabolic steroids, opioids); consider further evaluation

Two cautions apply to reading this table. First, hormone values inform classification but do not decide it definitively; occasional NOA cases have normal FSH, and occasional obstructed men have mild hormone shifts. Second, reference ranges vary between laboratories, and a value just outside the range is not a diagnosis by itself. What the panel reliably does is flag the situations — like hypogonadotropic hypogonadism — where treating a hormone problem can restore sperm to the ejaculate without any procedure at all.

Genetic Testing Before Retrieval: Why It Changes Decisions

For NOA, and for OA involving the vas deferens, published guidelines recommend genetic testing before scheduling sperm retrieval, because the results change both the retrieval plan and the IVF plan:

  • Karyotype (chromosome analysis). Detects Klinefelter syndrome and other chromosome abnormalities. Knowing this in advance shapes counseling: many Klinefelter conceptions end in miscarriage, sperm retrieved from men with Klinefelter syndrome can produce embryos with chromosome differences, and preimplantation genetic testing (PGT) plus prenatal testing become part of the plan. Our PGT in Torrance guide explains how embryos are screened.
  • Y-chromosome microdeletion testing (AZF regions). The AZF regions of the Y chromosome carry genes essential for sperm production. Complete deletions involving the AZFa or AZFb regions are associated with very low retrieval prospects in published data — knowing this before a retrieval prevents an expensive procedure with almost no chance of finding sperm. Isolated AZFc deletions, by contrast, are commonly compatible with successful retrieval. MedlinePlus Genetics describes the condition and its inheritance pattern (daughters inherit the Y-deletion-carrying chromosome only via fathers to sons; sons of a man with a deletion will carry it — MedlinePlus Genetics: Y chromosome infertility).
  • CFTR analysis. Standard when CBAVD is suspected. Importantly, guidelines recommend that if the man is found to carry a CFTR variant, the female partner is screened before proceeding, because a child inheriting variants from both parents would have cystic fibrosis. This sequencing protects the couple from learning about a serious reproductive risk after treatment rather than before it.
Genetic testing is not an academic exercise here — it can redirect the entire plan: which procedure, whether PGT is essential rather than optional, whether a retrieval is worth scheduling at all, and what a child could inherit. Professional society practice documents on male infertility evaluation (available through ASRM’s practice guidance library) treat genetic testing as a standard step in specific azoospermia situations, not an optional extra.

Treatable Causes First: Hormones and Medication Effects

Before any procedure is discussed, doctors look for causes that respond to medical treatment alone:

  • Hypogonadotropic hypogonadism. When FSH and LH are low, hormonal therapy (typically gonadotropin injections, sometimes after correcting an underlying pituitary issue) can restart sperm production. Published series report that sperm can reappear in the ejaculate over months of therapy in a substantial share of these men, and treatment is often tried before retrieval is considered. This is the clearest example of azoospermia that medication can reverse.
  • Exogenous testosterone and anabolic steroids. This surprises many men: testosterone therapy — prescribed or self-administered — suppresses sperm production and is a recognized cause of azoospermia. Stopping it (under medical supervision, with alternative treatment for the underlying low-testosterone symptoms) allows production to recover over months in many men. Our lifestyle and fertility guide touches on related supplement and substance issues.
  • Elevated prolactin or other pituitary problems. Prolactin-secreting issues suppress gonadotropins; treating the pituitary problem can restore signaling.
  • General health factors. Obesity, heavy alcohol use, and certain medications shift hormones against sperm production. These rarely cause azoospermia alone but compound other causes, and correcting them supports every other treatment path.

The sequencing principle is simple: fix what medicine can fix first. If hormones normalize and sperm return to the ejaculate, the couple may avoid procedures entirely or need far less invasive ones. If sperm never return, the retrieval pathway remains available.

Sperm Retrieval Procedures: TESA, TESE, and Micro-TESE

When sperm cannot be restored to the ejaculate medically, they can usually be retrieved directly from the reproductive tract. The four main techniques are:

Procedure How it works Typical use
TESA (testicular sperm aspiration) A fine needle draws tissue/sperm from the testicle; office-based, local anesthesia Obstructive azoospermia, and some NOA cases with expected scattered production
TESE (testicular sperm extraction) Small incisions remove tiny tissue samples from the testicle; examined in the lab OA and selected NOA; more tissue than aspiration
Micro-TESE An operating microscope is used to search the testicle for enlarged seminiferous tubules, the ones most likely to contain active production NOA — published guideline analyses report finding sperm roughly 1.5 times as often as conventional TESE in non-obstructive cases
MESA (epididymal sperm aspiration) Sperm are drawn from the epididymis, the collection point just above the testicle Obstructive azoospermia with an intact epididymis; yields large numbers of motile sperm

Retrieval outlook in published series: for obstructive azoospermia, sperm are recovered from nearly all men, in most series — the production side is intact, so the team simply collects from a known reservoir. For non-obstructive azoospermia, retrieval succeeds for roughly 40–60% of men across published series, with results varying by underlying cause, prior treatments, and technique. Micro-TESE improves the odds in NOA because it samples where production is actually visible, though it is a longer, more involved procedure performed by an experienced surgeon.

  • Recovery and risks. Needle-based techniques usually involve soreness for a few days; open procedures involve more. Recognized risks of any testicular procedure include bleeding, infection, and (rarely) injury to testicular blood supply affecting hormone function — risks your urology team should quantify for your specific case before you consent.
  • Timing with the IVF cycle. Retrieval can be coordinated on the day of egg retrieval (sperm used fresh) or done in advance with sperm frozen for later use — both approaches are well established in published practice. Freezing first avoids committing a partner’s cycle before knowing whether retrieval succeeds.

Using Retrieved Sperm: IVF With ICSI

Retrieved sperm — whether from a needle aspiration, a tissue sample, or a micro-TESE search — exist in numbers far too small for insemination in a dish or for IUI. They are used with ICSI, in which a single sperm is injected directly into a mature egg. This is the technique that converted azoospermia from a dead end into a treatment-eligible diagnosis; our male infertility and ICSI guide explains the procedure in detail, and the step-by-step IVF journey guide shows how a cycle fits together.

  • Egg retrieval for the female partner. The IVF cycle proceeds as in any IVF case: ovarian stimulation, egg retrieval, and fertilization by ICSI using the retrieved sperm. Our IVF in Torrance overview covers the full sequence.
  • PGT considerations. When azoospermia has a genetic cause — Klinefelter syndrome, Y-microdeletions, or CFTR findings — PGT-A and sometimes PGT-M become central rather than optional, because embryos can carry related chromosome or gene variants. Couples should expect genetic counseling before the cycle so that testing choices are made deliberately; see our PGT guide and our recurrent pregnancy loss guide for how chromosome findings connect to miscarriage risk.
  • What success looks like. Fertilization and embryo development with retrieved sperm are routinely achievable when sperm are found — including sperm recovered in very small numbers. Pregnancy chances per cycle depend overwhelmingly on female age and embryo quality, as our age and fertility guide explains; azoospermia itself, once solved by retrieval, is no longer the rate-limiting step in most cases.

Vasectomy: Reversal vs. Retrieval

For azoospermia after vasectomy, two legitimate paths exist, and the better choice depends on the couple’s specifics rather than on any universal rule:

  • Surgical reversal (vasovasostomy). Reconnects the vas. If it succeeds, sperm return to the ejaculate, and pregnancy can happen naturally or through IUI. It can take many months for counts to return, success rates fall with time since the vasectomy, and — even after a technically successful reversal — some men develop sperm antibodies or secondary blockage that keeps counts low. Reversal plus timed attempts can also consume a year or more of the female partner’s fertile window, which our age-and-fertility guide shows is a real cost for couples in their late 30s or beyond.
  • Sperm retrieval plus IVF/ICSI. Bypasses the vasectomy entirely: sperm are aspirated (TESA/MESA) and used with ICSI. The female partner undergoes an IVF cycle, so cost concentrates in the IVF side rather than the surgery side; pregnancy chances then track with the IVF cycle itself.

A practical framing many urologists use: the younger the female partner and the shorter the time since vasectomy, the more attractive reversal becomes (because natural conception remains possible afterwards); the older the female partner, or when IVF is needed for any other reason anyway, the more attractive retrieval-plus-ICSI becomes. IUI is only on the table if counts recover after reversal — see our IUI vs. IVF guide for how that decision is made.

If Retrieval Does Not Find Sperm: Paths Still Exist

Some men — particularly in NOA with certain genetic findings — will go through a well-planned retrieval and still have no usable sperm found. This is a hard conversation, and it deserves an honest one: no clinic can guarantee retrieval results, and a competent team tells you the odds before you spend money, not after. If retrieval fails, the paths that remain include:

  • Repeat or alternative retrieval. A single failed retrieval does not always close the door; published practice includes repeat micro-TESE in selected cases, and a specialist assessment of whether a second attempt has meaningful prospects is exactly the kind of question to ask directly.
  • Hormonal therapy followed by re-attempt. For men with mixed hormonal findings, correcting the hormone environment first can convert a failed retrieval into a successful one in some published reports.
  • Donor sperm. Using donor sperm with IUI or IVF makes biological motherhood possible even when a biological fatherhood is not. The decision carries real trade-offs in both directions: on one side, a clear path to pregnancy and a shared genetic connection with the mother; on the other, the absence of the male partner’s genetic link, identity questions for the child over time, and disclosure decisions that benefit from deliberate planning. Fertility counselors work with couples on exactly these decisions, and our guide to ovarian reserve and POI discusses the parallel decision involving donor eggs from the female side. Third-party reproduction raises the same core questions either way.
  • Non-biological paths. Some couples, after weighing retrieval odds, genetics, and cost, choose adoption or other family-building routes. None of these choices is a failure of effort; they are different answers to the same set of questions, and couples benefit from making them with clear information rather than under deadline pressure.

Whatever the path, the emotional weight of this stage is real and worth addressing deliberately — our guide to fertility stress and emotional support covers coping and counseling resources, and male-factor diagnosis carries a specific kind of grief that couples often under-acknowledge.

The Partner’s Evaluation and Practical Next Steps

Azoospermia is the male partner’s diagnosis, but treatment is a couple’s project, and the female partner’s evaluation should run in parallel, not after the retrieval question is settled. Ovarian reserve (see our AMH guide), age-related fertility (see age and fertility), uterine factors (see fibroids), ovulatory disorders such as PCOS, and tubal or pelvic factors (see tubal factor and endometriosis) all shape which path — retrieval-then-IVF, reversal-then-natural, donor sperm, or donor eggs — offers the best realistic chance. For couples with a prior pregnancy, our secondary infertility guide explains why new evaluations are still warranted on both sides. The full workup is mapped in our fertility testing guide, and the timing trigger for seeking care is defined by authoritative sources such as NICHD: twelve months of trying for women under 35, six months for women 35 and older (NICHD: About Infertility).

A practical checklist for the appointment where azoospermia is confirmed:

  • Ask for the repeat semen analysis with centrifugation (the "spin test") before anyone discusses prognosis.
  • Request the hormone panel — FSH, LH, testosterone, and prolactin — and ask what the pattern suggests about obstructive versus non-obstructive causes.
  • Ask which genetic tests are recommended for your specific situation (karyotype, Y-microdeletion, CFTR) and why; ask for female-partner screening where indicated.
  • Review all medications and supplements with the doctor — especially testosterone, anabolic steroids, and opioids — and ask whether stopping any of them is appropriate.
  • If retrieval is discussed, ask which technique (TESA, TESE, micro-TESE) is planned and why, and ask for the published retrieval ranges for men with your specific category and cause.
  • Ask whether sperm would be used fresh with a coordinated cycle or frozen first, and the reasoning.
  • Ask what happens if no sperm are found — before the procedure, not after.
  • Get costs, coverage, and every step in a written, individualized estimate; no clinic should ask you to proceed on verbal numbers.

If you are in Torrance or the South Bay and want to discuss a zero sperm count or a complex male-factor evaluation with a team that coordinates urologic assessment, genetic testing, and IVF under one roof, you can explore our full range of fertility services and schedule a consultation. Bring your semen analysis reports, your hormone results, and your questions — good answers start with complete information.

Frequently Asked Questions

Can azoospermia be treated?

Often, yes — though "treated" means different things in different categories. Hormonal causes such as hypogonadotropic hypogonadism can sometimes be reversed with medication, restoring sperm to the ejaculate. Obstructive azoospermia can usually be bypassed with sperm retrieval, which succeeds for nearly all obstructed men in published series. Non-obstructive azoospermia is harder: retrieval finds sperm for roughly 40–60% of men across published series, depending on cause and technique. And a few specific causes, such as complete AZFa or AZFb Y-chromosome deletions, make retrieval very unlikely — which is why genetic testing comes first.

Does a zero sperm count mean we cannot have a biological child?

No. The absence of sperm in the ejaculate does not equal the absence of sperm in the body. Men with obstructive azoospermia almost always have sperm that can be retrieved directly from the reproductive tract, and many men with non-obstructive azoospermia have small pockets of production that micro-TESE can find. Retrieved sperm are used with IVF and ICSI to create embryos. The exceptions are defined by genetics and testicular findings, which is exactly what the evaluation determines before treatment begins.

What is the difference between obstructive and non-obstructive azoospermia?

Obstructive azoospermia means sperm are produced normally but blocked from reaching the semen — by a missing or scarred duct, a vasectomy, infection, or prior surgery. Non-obstructive azoospermia means the testicles themselves make few or no mature sperm, usually because of genetic, developmental, hormonal, or toxic causes. The exam (testicle size) and hormone panel (especially FSH) usually distinguish them. The distinction matters because retrieval success rates and treatment planning differ substantially between the two.

How is sperm retrieved when the semen contains none?

Four main techniques exist, chosen by category: TESA (needle aspiration from the testicle), TESE (small tissue samples through a tiny incision), micro-TESE (an operating-microscope search of the testicle for areas of active production, used in non-obstructive cases), and MESA (aspiration from the epididymis in obstruction). Sperm retrieved this way are used with ICSI, in which a single sperm is injected into each mature egg. Retrieval can be coordinated with the partner’s egg retrieval or done in advance with the sperm frozen.

Should we do genetic testing before sperm retrieval?

In most azoospermia situations, yes — professional guidelines recommend it, and for practical reasons. Karyotyping finds Klinefelter syndrome and other chromosome abnormalities that shape counseling and embryo testing; Y-chromosome microdeletion testing identifies deletions that make retrieval very unlikely (preventing an expensive procedure with poor prospects) and those that allow it; CFTR testing is standard when the vas deferens is absent, with female-partner screening before proceeding. Knowing the genetics first changes which procedure is planned, whether PGT is essential, and what a future child could inherit.

Does taking testosterone help a zero sperm count?

No — and this is one of the most important things a man with azoospermia should know. Testosterone therapy (prescribed for low-T symptoms, or self-administered as anabolic steroids) suppresses the brain’s signals that drive sperm production, and it is a recognized cause of azoospermia. For men using it, stopping under medical supervision and treating symptoms another way often allows sperm production to recover over months. Men with a zero sperm count who want biological children should not start testosterone therapy without a fertility-focused discussion first.

For plain-language patient education on male fertility topics, ASRM’s patient library publishes fact sheets and booklets that pair well with this guide (ASRM patient fact sheets and booklets).

Medical and informational disclaimer: This article is general educational information, not medical advice, and it is not a substitute for evaluation by a qualified physician or urology specialist. Any statistics, percentages, or ranges mentioned are population-level figures from published research, guidelines, and authoritative sources (such as MedlinePlus, MedlinePlus Genetics, NICHD, and ASRM); they are typical ranges for groups, not predictions about any individual, and they are not clinic-specific results, guarantees, or quotes. Diagnosis, treatment options, retrieval outcomes, and costs should be discussed directly with your medical team in a written, individualized assessment or estimate before any decision.

Incinta Fertility Center — Fertility Clinic Torrance & South Bay, California

By the Incinta Editorial Team · Medically reviewed by the Incinta Review Team

Call us: +1 (424) 212-4087